Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP)

N. Y. L. Ngoi; T. Z. Tan; K. T. Kuay; A. C. Y. Tan; J. Y. Lee; M. Y. Pang; K. W. Tham; J. Chan; W. L. Wong; W. Y. Chay; D. Anne; M. Friedlander; S. Varma; T. Meniawy; G. Au-Yeung; C. Scott; L. Mileshkin; D. Bowtell; R. Y-J. Huang; D. S. P. Tan

doi:10.1016/j.annonc.2021.08.1179

Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP)

N. Y. L. Ngoi, T. Z. Tan, K. T. Kuay, A. C. Y. Tan, J. Y. Lee, M. Y. Pang, K. W. Tham, J. Chan, W. L. Wong, W. Y. Chay, D. Anne, M. Friedlander, S. Varma, T. Meniawy, G. Au-Yeung, C. Scott, L. Mileshkin, D. Bowtell, R. Y-J. Huang, D. S. P. Tan

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S736-S736
Number of pages	1
Journal	Annals of Oncology
Volume	32
DOIs	https://doi.org/10.1016/j.annonc.2021.08.1179
Publication status	Published - 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2021.08.1179

Cite this

Ngoi, N. Y. L., Tan, T. Z., Kuay, K. T., Tan, A. C. Y., Lee, J. Y., Pang, M. Y., Tham, K. W., Chan, J., Wong, W. L., Chay, W. Y., Anne, D., Friedlander, M., Varma, S., Meniawy, T., Au-Yeung, G., Scott, C., Mileshkin, L., Bowtell, D., Huang, R. Y.-J., & Tan, D. S. P. (2021). Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP). Annals of Oncology, 32, S736-S736. https://doi.org/10.1016/j.annonc.2021.08.1179

@article{8e45248d87f949079f453bcfee12d9df,

title = "Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP)",

author = "Ngoi, {N. Y. L.} and Tan, {T. Z.} and Kuay, {K. T.} and Tan, {A. C. Y.} and Lee, {J. Y.} and Pang, {M. Y.} and Tham, {K. W.} and J. Chan and Wong, {W. L.} and Chay, {W. Y.} and D. Anne and M. Friedlander and S. Varma and T. Meniawy and G. Au-Yeung and C. Scott and L. Mileshkin and D. Bowtell and Huang, {R. Y-J.} and Tan, {D. S. P.}",

year = "2021",

doi = "10.1016/j.annonc.2021.08.1179",

language = "English",

volume = "32",

pages = "S736--S736",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Ngoi, NYL, Tan, TZ, Kuay, KT, Tan, ACY, Lee, JY, Pang, MY, Tham, KW, Chan, J, Wong, WL, Chay, WY, Anne, D, Friedlander, M, Varma, S, Meniawy, T, Au-Yeung, G, Scott, C, Mileshkin, L, Bowtell, D, Huang, RY-J & Tan, DSP 2021, 'Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP)', Annals of Oncology, vol. 32, pp. S736-S736. https://doi.org/10.1016/j.annonc.2021.08.1179

TY - JOUR

T1 - Phase II study of IV vinorelbine in relapsed platinum resistant or refractory C5 high grade serous primary peritoneal, fallopian tube or ovarian cancer (VIP)

AU - Ngoi, N. Y. L.

AU - Tan, T. Z.

AU - Kuay, K. T.

AU - Tan, A. C. Y.

AU - Lee, J. Y.

AU - Pang, M. Y.

AU - Tham, K. W.

AU - Chan, J.

AU - Wong, W. L.

AU - Chay, W. Y.

AU - Anne, D.

AU - Friedlander, M.

AU - Varma, S.

AU - Meniawy, T.

AU - Au-Yeung, G.

AU - Scott, C.

AU - Mileshkin, L.

AU - Bowtell, D.

AU - Huang, R. Y-J.

AU - Tan, D. S. P.

PY - 2021

Y1 - 2021

U2 - 10.1016/j.annonc.2021.08.1179

DO - 10.1016/j.annonc.2021.08.1179

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 32

SP - S736-S736

JO - Annals of Oncology

JF - Annals of Oncology

ER -